Enlivex Therapeutics Ltd. Share Price Deutsche Boerse AG
Equities
1BT
IL0011319527
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.27 EUR | -1.55% | -8.63% | -44.78% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.52M 24.41M 2.09B |
---|---|---|---|---|---|
Net income 2024 * | -16M -14.72M -1.26B | Net income 2025 * | -12M -11.04M -945M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.64
x | P/E ratio 2025 * |
-2.56
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 80.79% |
1 day | -1.55% | ||
1 week | -8.63% | ||
Current month | -16.45% | ||
1 month | -11.81% | ||
3 months | -56.51% | ||
6 months | -19.62% | ||
Current year | -44.78% |
Managers | Title | Age | Since |
---|---|---|---|
Oren Hershkovitz
CEO | Chief Executive Officer | 47 | 15/11/19 |
Dror Mevorach
FOU | Founder | 68 | 31/12/08 |
Director of Finance/CFO | 47 | 31/12/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shai Novik
CHM | Chairman | 58 | 31/12/13 |
Avri Havron
BRD | Director/Board Member | 76 | 31/12/13 |
Brian Schwartz
BRD | Director/Board Member | 52 | 30/11/20 |
Date | Price | Change |
---|---|---|
17/05/24 | 1.27 | -1.55% |
16/05/24 | 1.29 | -2.27% |
15/05/24 | 1.32 | -0.75% |
14/05/24 | 1.33 | -2.92% |
13/05/24 | 1.37 | -1.44% |
Delayed Quote Deutsche Boerse AG, May 17, 2024 at 07:00 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- ENLV Stock
- 1BT Stock